The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Cyclodextrins as Drug Carrier Molecule: A Review
Open accessAbstract
A series of 5-methyl-7-phenyl-3H-thiazolo [4,5-b]pyridin-2-ones has been designed, synthesized, and characterized by spectral data.Target compounds were screened for their antimicrobial activity against some pathogenic bacteria and fungi, and most of them showed moderate activity, especially compound 3g, which displayed the potent inhibitory effect against Pseudomonas aeruginosa and Escherichia coli with MIC value of 0.21 µM.The active thiazolopyridine derivatives 3c, 3f, and 3g were screened for their cytotoxicity effects on HaCat, Balb/c 3T3 cells using MTT assay, which revealed promising results.In silico assessment for compounds 3c, 3f, and 3g also revealed suitable drug-like parameters and ADME properties.The binding interactions of the most active compound 3g were performed through molecular docking against MurD and DNA gyrase, with binding energies and an inhibitory constant compared to the reference drug ciprofloxacin.The tested thiazolo [4,5-b]pyridines constitute an exciting background for the further development of new synthetic antimicrobial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Methods for in vitro evaluating antimicrobial activity: A review
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2015.11.005 · Cited by 8,044
Higuchi, T., & Connors, A. (1965) · Cited by 2,554
The Stability of Cyclodextrin Complexes in Solution
Connors, K. A. (1997) · Chemical Reviews · doi:10.1021/cr960371r · Cited by 2,175
Cyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Cyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Industrial Applications of Cyclodextrins
Hedges, A. R. (1998) · Chemical Reviews · doi:10.1021/cr970014w · Cited by 1,068
Cyclodextrins and their inclusion complexes
Szejtli, J. (1982) · REAL-EOD (Library of the Hungarian Academy of Sciences and the Information Center Oriental Collection) · Cited by 970
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
A Practical Guide for the Determination of Binding Constants
Hirose, K. (2001) · Journal of inclusion phenomena and macrocyclic chemistry · doi:10.1023/a:1011117412693 · Cited by 605
Drug Delivery via the Mucous Membranes of the Oral Cavity
Harris, D., & Robinson, J. R. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810102 · Cited by 558
The utility of cyclodextrins for enhancing oral bioavailability
Carrier, R. L., Miller, L. A., & Ahmed, I. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.018 · Cited by 557
Cyclodextrins in topical drug formulations: theory and practice
Loftsson, T., & Masson, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00761-x · Cited by 475
Self-Association of Cyclodextrins and Cyclodextrin Complexes
Loftsson, T., Másson, M., & Brewster, M. E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20047 · Cited by 426
Design and Evaluation of Cyclodextrin-Based Drug Formulation
Uekama, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.900 · Cited by 356
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312
Effects of Cyclodextrins on Drug Delivery Through Biological Membranes
Loftsson, T., Vogensen, S. B., Brewster, M. E., & Konráðsdóttir, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20992 · Cited by 302
Cyclodextrins in peptide and protein delivery
Irie, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00057-x · Cited by 298
The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Al-Tel, T. H., Al-Qawasmeh, R. A., & Zaarour, R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.051 · Cited by 252
Sajeesh, S., & Sharma, C. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.019 · Cited by 250
Cyclodextrins in transdermal and rectal delivery
Matsuda, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00056-8 · Cited by 196
Development of formulations that enhance physical stability of viral vectors for gene therapy
Croyle, M., Cheng, X., & Wilson, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301527 · Cited by 188
Cyclodextrins in targeting Application to nanoparticles
Duchêne, D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00053-2 · Cited by 179
Systemic delivery of peptides and proteins across absorptive mucosae.
Sayani, A. P., & Chien, Y. W. (1996) · PubMed · Cited by 161
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G., & Schipper, N. G. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015896405389 · Cited by 146
Kang, J., Kumar, V., Yang, D. J., Chowdhury, P., & Hohl, R. J. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00214-7 · Cited by 144
Eissa, I. H., El‐Naggar, A. M., & El-Hashash, M. A. A. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.006 · Cited by 143
Figueiras, A., Carvalho, R. A., Ribeiro, L., Torres-Labandeira, J. J., & Veiga, F. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.005 · Cited by 135
Arima, H., Yunomae, K., Miyake, K., Irie, T., Hirayama, F., & Uekama, K. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1025 · Cited by 134
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin
Maestrelli, F., García-Fuentes, M., Mura, P., & Alonso, M. J. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.12.006 · Cited by 133
Becket, G., Schep, L. J., & Tan, M. Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00382-2 · Cited by 133
Spontaneous Opalescence of Aqueous γ-Cyclodextrin Solutions: Complex Formation or Self-Aggregation?
Szente, L., Szejtli, J., & Kis, G. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9704341 · Cited by 126
Shi, F. J., Li, C., Xia, M., Miao, K., Zhao, Y., Tu, S., Zheng, W., Zhang, G., & Ma, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.046 · Cited by 123
Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., Noda, S., & Uekama, K. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100556 · Cited by 120
Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray
Loftsson, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00580-9 · Cited by 116
Effect of Cyclodextrins on Topical Drug Delivery to the Eye
Loftsson, Þ., & Stefánsson, E. (1997) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049709148496 · Cited by 113
5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Witherington, J. J., Bordas, V., Garland, S. L., Hickey, D. M. B., Ife, R. J., Liddle, J., Saunders, M., Smith, D. G., & Ward, R. W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00134-3 · Cited by 107
Self-assemblies of amphiphilic cyclodextrins
Roux, M., Perly, B., & Djedaïni‐Pilard, F. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0207-6 · Cited by 103
Chioua, M., Samadi, A., Soriano, E., Lozach, O., Meijer, L., & Marco, J. L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.099 · Cited by 98
Kang, F., Jiang, G., Hinderliter, A. K., DeLuca, P. P., & Singh, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1015354028908 · Cited by 96
Minami, K., Hirayama, F., & Uekama, K. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9704339 · Cited by 91
Improvement of the Oral Bioavailability of Digitalis Glycosides by CyclodextrinComplexation
Uekama, K., FUJINAGA, T., Hirayama, F., Otagiri, M., Yamasaki, M., Seo, H., Hashimoto, T., & Tsuruoka, M. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721125 · Cited by 90
Kamada, M., Hirayama, F., Udo, K., et al. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00171-2 · Cited by 85
Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
Irie, T., Wakamatsu, K., Arima, H., Aritomi, H., & Uekama, K. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90053-5 · Cited by 84
Liposomes Containing Drug and Cyclodextrin Prepared by the One-Step Spray-Drying Method
Škalko‐Basnet, N., Pavelić, Ž., & Bećirević‐Laćan, M. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102309 · Cited by 82
Filipović‐Grčić, J., Voinovich, D., Moneghini, M., Bećirević‐Laćan, M., Magarotto, L., & Jalšenjak, I. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00078-0 · Cited by 77
Gao, H., Yang, Y., Fan, Y., & Ma, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.016 · Cited by 67
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
Loftsson, Þ., Friðriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03835.x · Cited by 65
Qian, L., Guan, Y. P., & Xiao, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.018 · Cited by 64
Kang, F., & Singh, J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00263-1 · Cited by 63
Soares, A. F., Carvalho, R. A., & Veiga, F. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.183 · Cited by 63
Synthesis and In Vitro Antioxidant Activity of some New Fused Pyridine Analogs
Al-Omar, M. A., Youssef, K. M., El‐Sherbeny, M. A., Awadalla, S. A. A., & El‐Subbagh, H. I. (2005) · Archiv der Pharmazie · doi:10.1002/ardp.200400953 · Cited by 61
Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin
Nagase, Y., Hirata, M., Wada, K., Arima, H., Hirayama, F., Irie, T., Kikuchi, M., & Uekama, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00851-1 · Cited by 60
Sortino, S., Giuffrida, S., Guidi, G. D., Chillemi, R., Petralia, S., Marconi, G., Condorelli, G. G., & Sciuto, S. (2001) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0730006tpofai2.0.co2 · Cited by 60
Felton, L. A., Wiley, C. J., & Godwin, D. A. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120014578 · Cited by 57
Sun, Q., Lin, G., Li, L., Jin, X.-T., Huang, L., Zhang, G., Yang, W. M., Chen, K., Xiang, R., Chen, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00665 · Cited by 57
Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug
Loftsson, Þ., & Stefánsson, E. (2007) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(07)50001-8 · Cited by 51
Nasal Absorption of Dihydroergotamine from Liquid and Powder Formulations in Rabbits
Marttin, E., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960500j · Cited by 51
A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues
Arabshahi, H. J., van Rensburg, M., Pilkington, L. I., Jeon, C. Y., Song, M., Gridel, L.-M., Leung, E. Y., Barker, D. L. A., Vuica‐Ross, M., Volcho, K. P., et al. (2015) · MedChemComm · doi:10.1039/c5md00245a · Cited by 50
Sukegawa, T., Furuike, T., Niikura, K., Yamagishi, A., Monde, K., & Nishimura, S. (2002) · Chemical Communications · doi:10.1039/b110673b · Cited by 50
Brewster, M. E., Loftsson, Þ., Estes, K. S., Lin, J.-L., Friđriksdóttir, H., & Bodor, N. S. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90121-h · Cited by 49
Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase
Tomašič, T., Zidar, N., Rupnik, V., Kovač, A., Blanot, D., Gobec, S., Kikelj, D., & Mašič, L. P. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.129 · Cited by 48
Zidar, N., Tomašič, T., Šink, R., Kovač, A., Patin, D., Blanot, D., Contreras‐Martel, C., Dessen, A., Premru, M. M., Zega, A., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.017 · Cited by 47
Acute hormonal response to sublingual androstenediol intake in young men
Brown, G. A., Martini, E. R., Roberts, B., Vukovich, M. D., & King, D. S. (2002) · Journal of Applied Physiology · doi:10.1152/jappl.2002.92.1.142 · Cited by 47
Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs
Lim, H. J., Cho, E. C., Shim, J., Kim, D., An, E. J., & Kim, J. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.01.025 · Cited by 44
Ueda, H., Ou, D., Endo, T., Nagase, H., Tomono, K., & NAGAI, T. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809088532 · Cited by 43
Increased bioavailability of clomipramine after sublingual administration in rats
Yoo, S. D., Yoon, B. M., Lee, H. S., & Lee, K. C. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990163p · Cited by 36
Khodarahmi, G., Asadi, P., Farrokhpour, H., Hassanzadeh, F., & Dinari, M. (2015) · RSC Advances · doi:10.1039/c5ra10097f · Cited by 35
Antibiotic resistance needs global solutions
Aiken, A. M., Allegranzi, B., Scott, J. A. G., Mehtar, S., Pittet, D., & Grundmann, H. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70709-1 · Cited by 34
INTERACTIONS BETWEEN CYCLODEXTRINS AND OPHTHALMIC DRUGS
Vandoorne, H. (1993) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 34
Lozynskyi, A., Zimenkovsky, B. S., Radko, L., Stypuła-Trębas, S., Roman, O., Gzella, A. K., & Lesyk, R. (2017) · Chemical Papers · doi:10.1007/s11696-017-0318-1 · Cited by 31
The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer
Loftsson, Þ., Sigfússon, S. D., Sigurðsson, H. H., & Másson, M. (2003) · Stp Pharma Sciences · Cited by 28
Dexamethasone delivery to posterior segment of the eye
Loftsson, Þ., Sigurðsson, H. H., Hreinsdóttir, D., Konrádsdóttir, F., & Stefánsson, E. (2007) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-006-9253-4 · Cited by 27
Lozynskyi, A., Zimenkovsky, B. S., Nektegayev, I. A., & Lesyk, R. (2015) · Heterocyclic Communications · doi:10.1515/hc-2014-0204 · Cited by 27
Fujita, M., Seki, T., & Ikeda, N. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00332-3 · Cited by 26
Investigations into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres
Bibby, D. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00004-6 · Cited by 21
Influence of β - cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT)
Mehramizi, A., Monfared, E. A., Bayati, K., Tehrani, M. R., Pourfarzib, M., & Dorkoush, F. (2007) · DARU Journal of Pharmaceutical Sciences · Cited by 19
Tasic, L. M., Jovanović, M. D., & Djurić, Z. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb14363.x · Cited by 18
Londhe, V. Y., & Nagarsenker, M. S. (1999) · Indian Journal of Pharmaceutical Sciences · Cited by 15
Antimicrobial and cytotoxic activities of thiazolo[4,5-b]pyridine derivatives
Lozynskyi, A., Derkach, H., Zasidko, V. V., Konechnyi, Y., Finiuk, N. S., Len, J., Kutsyk, R., Регеда, М., & Lesyk, R. (2021) · Biopolymers and Cell · doi:10.7124/bc.000a53 · Cited by 13
Progress in the chemistry of 5-acetylthiazoles
Bondock, S., Albormani, O., Fouda, A. M., & Safieh, K. A. A. (2016) · Synthetic Communications · doi:10.1080/00397911.2016.1180700 · Cited by 11
Interaction of trimeprazine with cyclodextrins in aqueous solution.
Lutka, A., & Koziara, J. M. (2000) · PubMed · Cited by 11
Wu, W. ‐., Wu, J., & Bodor, N. (2002) · PubMed · Cited by 9
(1998) · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
Cited by
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Cyclodextrins as encapsulation agents for plant bioactive compounds
Pinho, E., Grootveld, M., Soares, G., & Henriques, M. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.08.078 · Cited by 422
Delivery systems for liquid food products
Sagalowicz, L., & Leser, M. E. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2009.12.003 · Cited by 375
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 331
Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications
Poulson, B. G., Alsulami, Q. A., Sharfalddin, A., El Agammy, E. F., Mouffouk, F., Emwas, A.-H., Jaremko, L., & Jaremko, M. (2021) · Polysaccharides · doi:10.3390/polysaccharides3010001 · Cited by 312
Metadata
- Authors
- Rasheed, A.
- Venue
- Scientia Pharmaceutica
- Publisher
- MDPI AG
- Published
- 2008
- Volume
- 76
- Issue
- 4
- Pages
- 567-598
- ISSN
- 0036-8709 (ISSN-L)
- OpenAlex
- W2119904380
- Cited by
- 394
- References
- 91
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.